Mapping lung tumor cell drug responses as a function of matrix context and genotype using cell microarrays
Author:
Affiliation:
1. Department of Bioengineering
2. University of Illinois at Urbana–Champaign
3. Urbana
4. USA
5. Department of Molecular Medicine
6. Mayo Clinic
7. Rochester
Abstract
A combinatorial cell microarray platform to map the impact of both extracellular matrix proteins and genotype on the drug responses of tumor cells.
Funder
University of Illinois at Urbana-Champaign
Publisher
Oxford University Press (OUP)
Subject
Biochemistry,Biophysics
Link
http://pubs.rsc.org/en/content/articlepdf/2016/IB/C6IB00179C
Reference62 articles.
1. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2. Management of non-small-cell lung cancer: recent developments
3. Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer
4. Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
5. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in high throughput cell culture technologies for therapeutic screening and biological discovery applications;Bioengineering & Translational Medicine;2023-12-04
2. Mechanobiology of cancer cell responsiveness to chemotherapy and immunotherapy: Mechanistic insights and biomaterial platforms;Advanced Drug Delivery Reviews;2023-05
3. Development of bone cell microarrays in microfluidic chips for studying osteocyte-osteoblast communication under fluid flow mechanical loading;Biofabrication;2022-02-02
4. 3D spiral channels combined with flexible micro-sieve for high-throughput rare tumor cell enrichment and assay from clinical pleural effusion samples;Bio-Design and Manufacturing;2022-01-15
5. The Influence of Tissue Architecture on Drug Response: Anticancer Drug Development in High-Dimensional Combinatorial Microenvironment Platforms;Biomarkers of the Tumor Microenvironment;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3